Article Information
History
- March 7, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Alex L. Roederer1,
- Yi Cao1,
- Kerri St. Denis1,
- Maegan L. Sheehan1,
- Chia Jung Li1,
- Evan C. Lam1,
- David J. Gregory2,3,
- Mark C. Poznansky2,4,
- A. John Iafrate5,
- David H. Canaday6,7,
- Stefan Gravenstein8,9,10,
- Wilfredo F. Garcia-Beltran1,5 and
- Alejandro B. Balazs1,*
- 1Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA
- 2Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, 02129, USA
- 3Pediatric Infectious Disease, Massachusetts General Hospital for Children, Boston, MA 02114, USA
- 4Massachusetts General Hospital Cancer Center, Boston, MA, 02114, USA
- 5Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA
- 6Case Western Reserve University School of Medicine, Cleveland, OH
- 7Geriatric Research Education and Clinical Center, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
- 8Center of Innovation in Long-Term Services and Supports, Veterans Administration Medical Center, Providence, Rhode Island
- 9Division of Geriatrics and Palliative Medicine, Alpert Medical School of Brown University, Providence, Rhode Island, USA
- 10Brown University School of Public Health Center for Gerontology and Healthcare Research, Providence, Rhode Island
- ↵*Lead contact; correspondence: abalazs{at}mgh.harvard.edu
Posted March 07, 2024.
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
